The remote patient monitoring (RPM) technology that a patient uses while receiving hospital-at-home care does not follow a ...
CGM traces added to DCCT data can predict microvascular diabetes complications similarly to glycated hemoglobin.
New research suggests that wearing continuous glucose monitors could lower the risk of dementia. Experts discuss how symptoms can overlap between diabetes and dementia.
When you buy through our links, we may earn a commission. Learn more› By Dave Gershgorn Dave Gershgorn is a writer covering monitors, laptops, and tablets. He is a certified display calibrator ...
Continuous glucose monitors, or CGMs, are devices that track blood sugar in real-time and can tell wearers how their bodies react to stress, food, sleep or exercise.
Beta Bionics has begun life as a public company with a $204m initial public offering (IPO), significantly higher than its anticipated target. The US-based company sold 12 million shares of its common ...
Medical device and healthcare company Abbott has opened a new facility in Kilkenny, which is expected to employ 800 people.
Investors feel optimistic about Abbott's robust strength in the Core Diagnostics business. Yet, unfavorable forex impacts are concerning.
With a solid foundation for growth and a promising outlook, the global lancet market is on track to achieve its projected USD ...
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...
Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...
Abbott Laboratories is a well-diversified health care company, with four distinct units: medical devices, diagnostics, ...